← Leaderboards
Douglas Gould
University Of California, San Francisco
$18,350,835
Attributed
$25,685,820
Total exposure
14
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.8M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$25,685,820 · 14
By mechanism
R01$15,276,626 · 6
RF1$5,769,735 · 2
R33$2,624,637 · 1
R61$1,065,697 · 1
R21$895,125 · 2
R13$54,000 · 2
Top collaborators
- Scott Earley9 shared
- Myriam Marianne Chaumeil7 shared
- Scott A Oakes6 shared
- Feroz R Papa6 shared
- Patricia L Musolino1 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Myriam Marianne Chaumeil$7,418,051
Others in their field
Top investigators on “Genetic”
- Richard A Gibbs · Baylor College Of Medicine$577,061,667
- Eric S Lander · Whitehead Institute For Biomedical Res$560,806,052
- David R. Weir · University Of Michigan At Ann Arbor$322,225,557
- Richard K. Wilson · Washington University$316,685,275
- Lawrence Corey · Fred Hutchinson Cancer Center$312,182,347
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$302,429,647
Research focus
GeneticMutationMolecularPathway InteractionsGenesCellsMutant Strains MiceLeadPathogenesisPreventSignal TransductionMutantBasement MembraneProteinsMouse ModelInsightCollagen Type IvGenetic ResourcePathologyPhysiologicalDefectMediatingBlood VesselsEtiology
Grant awards (49)
Mechanistic and Functional Evaluation of a Model of Cerebral Small Vessel Disease$770,502
R01 · FY2025 · NS · contact PI
Genetically testing mechanisms of ocular development and disease$710,744
R01 · FY2025 · EY · contact PI
Development of novel genetic tools for the study of type IV collagens$205,000
R21 · FY2025 · DK · contact PI
2025 Collagen Gordon Research Conference and Gordon Research Seminar$25,000
R13 · FY2025 · AR · contact PI
Development of novel genetic tools for the study of type IV collagens$246,000
R21 · FY2024 · DK · contact PI
Gene therapy for disorders of the extracellular matrix$2,481,348
RF1 · FY2023 · NS · contact PI
Development and validation of novel models for cerebral small vessel disease and vascular cognitive impairment$783,698
R33 · FY2023 · NS · contact PI
Characterization of Tagged Type IV Collagen$444,125
R21 · FY2023 · NS · contact PI
Development and validation of novel models for cerebral small vessel disease and vascular cognitive impairment$155,505
R33 · FY2023 · NS · contact PI
Diversity Supplement-Massoudi$106,768
R33 · FY2023 · NS · contact PI
2023 Collagen Gordon Research Conference and Seminar$29,000
R13 · FY2023 · AR · contact PI
Development and validation of novel models for cerebral small vessel disease and vascular cognitive impairment$782,056
R33 · FY2022 · NS · contact PI
Role of the Unfolded Protein Response in Photoreceptor Degeneration$549,721
R01 · FY2022 · EY · contact PI
Genetically testing mechanisms of ocular development and disease$391,638
R01 · FY2022 · EY · contact PI
Mechanisms of Functional Vascular Impairment In Genetic Models of Cerebral Small Vessel Disease$156,235
RF1 · FY2022 · NS · contact PI
Development and validation of novel models for cerebral small vessel disease and vascular cognitive impairment$796,610
R33 · FY2021 · NS · contact PI
Genetic and Mechanistic Study of Cerebral Small Vessel Disease$610,644
R01 · FY2021 · NS · contact PI
Role of the Unfolded Protein Response in Photoreceptor Degeneration$549,722
R01 · FY2021 · EY · contact PI
Genetically testing mechanisms of ocular development and disease$391,637
R01 · FY2021 · EY · contact PI
Genetically testing mechanisms of ocular development and disease$117,503
R01 · FY2021 · EY · contact PI
Genetic and Mechanistic Study of Cerebral Small Vessel Disease$614,451
R01 · FY2020 · NS · contact PI
Role of the Unfolded Protein Response in Photoreceptor Degeneration$565,262
R01 · FY2020 · EY · contact PI
Development and validation of novel models for cerebral small vessel disease and vascular cognitive impairment$560,704
R61 · FY2020 · NS · contact PI
Genetically testing mechanisms of ocular development and disease$403,750
R01 · FY2020 · EY · contact PI
Genetic and Mechanistic Study of Cerebral Small Vessel Disease$763,643
R01 · FY2019 · NS · contact PI
Role of the Unfolded Protein Response in Photoreceptor Degeneration$562,484
R01 · FY2019 · EY · contact PI
Development and validation of novel models for cerebral small vessel disease and vascular cognitive impairment$504,993
R61 · FY2019 · NS · contact PI
Genetically testing mechanisms of ocular development and disease$400,000
R01 · FY2019 · EY · contact PI
Role of the Unfolded Protein Response in Photoreceptor Degeneration$196,924
R01 · FY2019 · EY · contact PI
Genetically testing mechanisms of ocular development and disease$78,815
R01 · FY2019 · EY · contact PI
Mechanisms of Functional Vascular Impairment In Genetic Models of Cerebral Small Vessel Disease$3,132,152
RF1 · FY2018 · NS · contact PI
Genetic and Mechanistic Study of Cerebral Small Vessel Disease$729,815
R01 · FY2018 · NS · contact PI
Role of the Unfolded Protein Response in Photoreceptor Degeneration$560,729
R01 · FY2018 · EY · contact PI
Genetically testing mechanisms of ocular development and disease$398,750
R01 · FY2018 · EY · contact PI
Genetic and Mechanistic Study of Cerebral Small Vessel Disease$771,932
R01 · FY2017 · NS · contact PI
Investigating the extracellular matrix in vascular development and maintenance$346,719
R01 · FY2017 · NS · contact PI
Investigating the extracellular matrix in vascular development and maintenance$346,719
R01 · FY2016 · NS · contact PI
Investigating the extracellular matrix in vascular development and maintenance$346,719
R01 · FY2015 · NS · contact PI
Genetically testing mechanisms of ocular development and disease$378,525
R01 · FY2014 · EY · contact PI
Investigating the extracellular matrix in vascular development and maintenance$345,625
R01 · FY2014 · NS · contact PI
Genetically testing mechanisms of ocular development and disease$366,938
R01 · FY2013 · EY · contact PI
Genetically testing interactions of ER and oxidative stresses in retinal disease$348,737
R01 · FY2013 · EY · contact PI
Genetically testing mechanisms of ocular development and disease$386,250
R01 · FY2012 · EY · contact PI
Genetically testing interactions of ER and oxidative stresses in retinal disease$367,092
R01 · FY2012 · EY · contact PI
Genetically testing mechanisms of ocular development and disease$386,250
R01 · FY2011 · EY · contact PI
Genetically testing interactions of ER and oxidative stresses in retinal disease$367,092
R01 · FY2011 · EY · contact PI
Genetically testing mechanisms of ocular development and disease$382,656
R01 · FY2010 · EY · contact PI
Genetically testing interactions of ER and oxidative stresses in retinal disease$382,388
R01 · FY2010 · EY · contact PI
Genetically testing interactions of ER and oxidative stresses in retinal disease$386,250
R01 · FY2009 · EY · contact PI